Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging
    Irving Kushner, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 535-537;

    CRP elevations are a sensitive test for inflammation, hut are not specific.

  • You have access
    It’s a rave new world: Rave culture and illicit drug use in the young
    Ellen S. Rome, MD, MPH
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 541-550;

    New and potentially dangerous illicit drugs are popular among young people today.

  • You have access
    C-reactive protein: A ‘golden marker’ for inflammation and coronary artery disease
    Vasant B. Patel, MD, Mark A. Robbins, MD and Eric J. Topol, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 521-534;

    Elevated levels of CRP are associated with increased cardiovascular risk.

  • You have access
    The promise and reality of nitric oxide in the diagnosis and treatment of lung disease
    Raed A. Dweik, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 486-493;

    Extensive research has shown mixed results.

  • You have access
    C-reactive protein: It’s back
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 475;

    Who would have thought that CRP, long used in rheumatology, would be a marker of coronary disease?

  • When should digoxin be used in patients with diastolic dysfunction?
    You have access
    When should digoxin be used in patients with diastolic dysfunction?
    M. Hilal Yamani, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 481;

    Treatment with digoxin must be individualized.

  • You have access
    Using aspirin and ACE inhibitors in combination: Why the hullabaloo?
    John G. Peterson, MD and Michael S. Lauer, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 569-574;

    What is the cause of this patient’s symptoms? A self-test on a clinical case.

  • You have access
    West Nile fever: Here to stay and spreading
    James Pile, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 553-560;

    Most cases are asymptomatic, but some patients develop encephalitis or even die. Public health measures are paramount.

  • You have access
    Microbial drug resistance and the roles of the new antibiotics
    David L. Longworth, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 496-504;

    Indiscriminate use of broad-spectrum antibiotics such as vancomycin and quinolones is promoting antibiotic resistance.

  • You have access
    Inflammatory myopathies: Narrowing the differential diagnosis
    Karen Rendt, MD
    Cleveland Clinic Journal of Medicine June 2001, 68 (6) 505-519;

    How to differentiate inflammatory myopathy from other causes of muscle weakness.

Pages

  • Previous
  • Next
  • 1
  • …
  • 402
  • 403
  • 404
  • 405
  • 406
  • 407
  • 408
  • 409
  • 410
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire